Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 99,892 | 28,203 | 0 | 0 | 0 |
| Cost of Goods | 2,185 | 571 | 0 | N/A | 3,137 |
| Gross Profit | 97,707 | 27,632 | N/A | N/A | -3,137 |
| Operating Expenses | 148,640 | 108,011 | 24,773 | 30,257 | 264 |
| Operating Income | -50,748 | -79,808 | -24,773 | -30,257 | -3,264 |
| Interest Expense | 8,348 | 12,156 | 46 | 84 | 0 |
| Other Income | 164,563 | -21,434 | -9,730 | -3 | -5 |
| Pre-tax Income | 105,467 | -113,398 | -34,549 | -30,344 | -3,268 |
| Income Tax | -11,770 | -2,460 | 76 | N/A | N/A |
| Net Income Continuous | 117,237 | -110,938 | -34,625 | -30,344 | -3,268 |
| Net Income | $117,237 | $-110,938 | $-34,625 | $-30,344 | $-3,268 |
| EPS Basic Total Ops | 3.49 | -4.43 | -2.44 | -8.29 | -1.59 |
| EPS Basic Continuous Ops | 3.49 | -4.43 | -2.44 | -8.29 | -1.59 |
| EPS Diluted Total Ops | 3.17 | -4.43 | -2.44 | -8.29 | -1.59 |
| EPS Diluted Continuous Ops | 3.12 | -4.43 | -2.44 | -8.29 | -1.59 |
| EBITDA(a) | $-30,908 | $-73,323 | $-24,557 | $-30,132 | $-3,263 |